Methods of treating tauopathies
Deuterated polyunsaturated fatty acids address oxidative stress and mitochondrial dysfunction in tauopathies by inhibiting lipid peroxidation and stabilizing neurons, effectively halting the progression of neurodegenerative diseases.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-11-25
- Publication Date
- 2026-03-04
AI Technical Summary
Current pharmaceutical treatments for neurodegenerative tauopathies, such as Lewy body diseases and proteinopathies, are inadequate in addressing oxidative stress and mitochondrial dysfunction, which contribute to the progression of diseases like Alzheimer's and Parkinson's, leading to neuronal damage and death.
Administration of deuterated polyunsaturated fatty acids (PUFAs) or their derivatives to inhibit lipid peroxidation and stabilize neuronal cells, reducing abnormal tau-associated neuronal death by attenuating lipid peroxidation and preventing mitochondrial dysfunction.
The method effectively reduces lipid peroxidation and stabilizes neurons, thereby inhibiting the progression of tauopathies and associated neurodegenerative diseases by preventing abnormal tau aggregation and mitochondrial damage.
Smart Images
Figure 2026035680000001 
Figure 2026035680000002 
Figure 2026035680000003